Zusammenfassung
Seit der Einführung des ersten porösen Orbitaimplantats als Bulbusersatz in Form eines korallinen Hydroxylapatits in den frühen 80er-Jahren des vergangenen Jahrhunderts stehen zahlreiche weitere modifizierte poröse Implantattypen zur Verfügung. Aufgrund des unterschiedlichen Designs der bisher vorhandenen Studien zur Langzeitverträglichkeit und aufgrund der zum Teil kurzen Nachbeobachtungszeit ist keiner der Implantattypen klar zu favorisieren. Einflussfaktoren auf die Expositionsrate scheinen u. a. die Ummantelung des Implantats, die chirurgische Technik und die operative Ausgangssituation zu sein.
Abstract
Since the introduction of the first coralline hydroxyapatite porous orbital implant as eye replacement in the early 1980s, numerous other modified porous implants have been developed. Due to the different design of the existing studies concerning long-term safety with, in some cases, relatively short follow-up, a comparison is difficult and none of the implant types can be clearly identified as being superior. Factors affecting the exposure rate of the implant seem to be the implant coating, the surgical technique and the condition of the patient’s tissue at the beginning of surgery.
Literatur
Alwitry A, West S, King J, Foss AJ et al (2007) Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg 23:11–15
Bilyk JR, Rubin PA, Shore JW (1992) Correction of enophthalmos with porous polyethylene implants. Int Ophthalmol Clin 32:151–156
Blaydon SM, Shepler TR, Neuhaus RW et al (2003) The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthal Plast Reconstr Surg 19:364–371
Chen YH, Cui HG (2006) High density porous polyethylene material (Medpor) as an unwrapped orbital implant. J Zhejiang Univ Sci B 7:679–682
Cleres B, Emmerich KH, Meyer-Rüsenberg HW (2011) Verträglichkeit eines Polymer ummantelten Bio-eye Hydroxylapatits (Coated HA) als Orbitaimplantat versus eines Sklera ummantelten Hydroxylapatit-Implantats, Poster DOG, Berlin
Colen TP, Paridaens DA, Lemij HG et al (2000) Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology 107:1889–1894
Custer PL (2000) Enucleation. Past, present and future. Ophthal Plast Reconstr Surg 16:316–321
Custer PL, Trinkaus KM, Fornoff J (1999) Comparative motility of hydroxyapatite and alloplastic enucleation implants. Ophthalmology 106:513–516
Cyster LA, Grant DM, Howdle SM et al (2005) The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering. Biomaterials 26:697–702
Duffy P, Wolf J, Collins G et al (1974) Possible person to person transmission of Creuzfeld-Jakob disease. N Engl J Med 290:692–693
Edelstein C, Shields CL, De Potter P et al (1997) Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 104:1616–1621
Fahim DK, Frueh BR, Musch DC et al (2007) Complications of pegged and non-pegged hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 23:206–210
Fan JT, Robertson DM (1995) Long-term follow-up of the Allen implant. 1967 to 1991. Ophthalmology 102:510–516
Frost WA (1887) What ist the best method of dealing with the lost eye? Br Med J 1:1153–1154
Gayre GS, Lipham W, Dutton JJ (2002) A comparison of rates fibrovascular ingrowth in wrapped verus unwrapped hydroxyapatite spheres in a rabbit model. Ophthal Plast Reconstr Surg 18:275–280
Guillinta P, Vasani SN, Granet DB et al (2003) Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophtal Plast Reconstr Surg 19:119–122
Gupta M, Puri P, Rennie IG (2002) Use of bovine pericardium as a wrapping material for hydroxyapatite orbital implants. Br J Ophthalmol 86:288–289
Guthoff R, Vick HP, Schaudig U (1995) Zur Prophylaxe des Postenukleationssyndrom: Das Hydroxylapatitsilikon-Implantat. Experimentelle Vorarbeiten und erste klinische Erfahrungen. Ophthalmologe 92:198–205
Habibovic P, Yuan H, Valk CM van der et al (2005) 3D microenviroment as essential element for osteoinduction by biomaterials. Biomaterials 26:3565–3575
Hing KA, Best SM, Tanner KE et al (2004) Mediation of bone ingrowth in porous hydroxapatite bone graft substitutes. J Biomed Mater Res A 68:187–200
Hornblass A, Biesman BS, Eviatar JA (1995) Current technique of enucleation: a survey of 5, 439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 11:77–88
Iordanidou V, De Potter P (2004) Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol 138:425–429
Johnson RLC, Ramstead CL, Nathoo N (2011) Pegging the porous orbital implant. Ophthal Plast Reconstr Surg 27:74–75
Jordan DR, Brownstein S, Dorey M et al (2004) Fibrovascularization of porous polyethylene (Medpor) orbital implant in a rabbit model. Ophthal Plast Reconstr Surg 20:136–143
Jordan DR, Chan S, Mawn L et al (1999) Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 106:505–512
Jordan DR, Gilberg S, Bawazeer A (2004) Coralline hydroxyapatite orbital implant (bio-eye): experience with 158 patients. Ophthal Plast Reconstr Surg 20:69–74
Jordan DR, Gilberg S, Mawn LA (2003) The bioceramic orbital implant: experience with 107 implants. Ophthal Plast Reconstr Surg 19:128–135
Jordan DR, Hwang I, Brownstein S et al (2000) The Molteno M-Sphere. Ophthal Plast Reconstr Surg 16:356–362
Jordan DR, Klapper SR, Gilber SM (2003) The use of vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg 19:53–61
Jordan DR, Mawn LA, Browstein S et al (2000) The bioceramic orbital implant: a new generation of porous implants. Ophthal Plast Reconstr Surg 16:347–355
Jordan DR, Munro SM, Brownstein S et al (1998) A synthetic hydroxyapatite implant: the so-called counterfeit implant. Ophthal Plast Reconstr Surg 14:244–249
Karesh JW, Dresner SC (1994) High-density porous polyethylene (Medpor) as a successful anophtalmic socket implant. Ophthalmology 101:1688–1696
Kassaee A, Kashkouli MB, Panjtanpanah M et al (2006) Mersilene mesh versus sclera in wrapping hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 22:41–44
Klapper SR, Jordan DR, Ells A et al (2003) Hydroxyapatite orbital implant vascularization assessed by magnetic resonance imaging. Ophthal Plast Reconstr Surg 19:46–52
Klett A, Guthoff R (2003) Wie lässt sich die Prothesenmotilität verbessern? Der Einfluss von Fornixtiefe und Gewebsdicke vor einem Hydroxylapatitsilikon-Implantat bei 66 Patienten. Ophthalmologe 100:445–448
Lin CJ, Liao SL, Jou JR et al (2002) Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol 4:394–396
Lumbroso L, Levy C, Plancher C et al (2000) Complications of hydroxyapatit orbital implants in children: a series of 105 cases. J Fr Ophtalmol 23:249–254
Lusky M, Weinreb RN (1992) Preservation of scleral grafts to avoid HIV infection. J Glaukoma 1:221
Mawn LA, Jordan DR, Gilberg S (1998) Scanning electron microscopic examination of porous orbital implants. Can J Ophthalmol 33:203–209
Mules PH (1885) Evisceration of the globe with artificial vitreous. Trans Ophthalmol Soc U K 5:200–206
Norda AG, Meyer-Rüsenberg HW (1998) Hydroxylapatitplomben-Implantation nach Enukleation – Erfahrungen in 112 Fällen. Spektrum Augenheilkd 12:101–107
Norda AG, Meyer-Rüsenberg HW (2000) Langzeitresultate mit der Implantation von Hydroxylapatit als Bulbusersatz. Ophthalmologe 97:91–99
Nunery WR, Heinz GW, Bonnin JM et al (1993) Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 9:96–104
Perry AC (1991) Advances in enucleation. Ophthalmol Clin North Am 4:173–182
Rosen HM, McFarland MM (1990) The biologic behavior of hydroxyapatite implanted into the maxillofacial skeleton. Plast Reconstr Surg 85:718–723
Sadiq SA, Mengher LS, Lowry J et al (2008) Integrated orbital implants – a comparison of hydroxyapatite and porous polyethylene implants. Orbit 27:37–40
Seiff SR, Chang JS, Hurt MH et al (1994) Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol 118:528–530
Shields JA, Shields CL, De Poter P (1993) Hydroxyapatite orbital implant after enucleation- experience with 200 cases. Mayo Clin Proc 68:1191–1195
Shields CL, Shields JA, De Potter P et al (1993) Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 91:177–195
Shields CL, Shields JA, Eagle RC et al (1991) Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 111:363–366
Shields CL, Uysal Y, Marr BP et al (2007) Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients. Ophthalmology 114:367–373
Su GW, Yen MT (2004) Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg 20:274–280
Suter AJ, Molteno ACB, Bevin TH et al (2002) Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 86:1287–1292
Tabatabaee Z, Mazloumi M, Rajabi MT et al (2011) Comparison of the exposure rate of wrapped hydroxyapatite (Bio-eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthal Plast Reconstr Surg 27:114–118
Toh TY, Bevin TH, Molteno ACB (2008) Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants. Clin Experiment Ophthalmol 36:756–761
Trichopoulas N, Ausburger JJ (2005) Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthal Plast Reconstr Surg 21:331–336
Tyres AG, Collin JR (1985) Baseball orbital implants: a review of 39 patients. Br J Ophthalmol 69:438–442
Van Acker E, De Potter P (2001) Porous polyethylene (Medpor) orbital implantat. Prospective study of 75 primary implantations. J Fr Ophtalmol 24:1067–1073
Einhaltung ethischer Richtlinien
Interessenkonflikt. B. Cleres und H.W. Meyer-Rüsenberg geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cleres, B., Meyer-Rüsenberg, H. Poröse Orbitaimplantate. Ophthalmologe 111, 572–576 (2014). https://doi.org/10.1007/s00347-013-2950-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-2950-7